Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
![Imatge de Publicacions](/sites/default/files/styles/3_1_small/public/2022-11/Portada_publicacions-petita_0.jpg?h=c6980913&itok=oZMso2V6)
Determinants of HIV-1 Late Presentation in Patients Followed in Europe.
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
Diversity and Evolution of HIV and HCV.
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies.
Ultrasound-Based Assessment of Preperitoneal Fat as a Surrogate Marker of Cardiovascular Risk: Comparative Study Between People Living With HIV and Controls.
Caffeine, a Risk Factor for Osteoarthritis and Longitudinal Bone Growth Inhibition.
New Drugs, Old Toxicities: Pneumonitis Related to Palbociclib - A Case Report.
-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants.
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.